RxDoctor Payments Data

Charles Lettvin, MD

Orthopaedic Surgery · Bannockburn, ILNPI 1427002344

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 49.0% of the total. Reporting peaked in 2021 at $596 and has fallen 87.4% since, to $75 in 2024. That places this record below the midpoint for orthopaedic surgery clinicians in IL, where the typical reported total is $3,100.

$1,574in general payments, 2019–2025

Across 91 payments — averaging $17.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Therapeutics, Inc.$772
  • Amgen$174
  • Ferring Pharmaceuticals Inc.$168
  • Bioventus LLC$113
  • Pacira Pharmaceuticals Incorporated$79
  • Kerecis Limited$57
  • plus $212 from 9 others

What the payments were for

  • Food & beverage$1,574100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,574 in reported general payments places this provider in the 35th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$547,798
Medicare patients
1,042
Services billed
15,787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen159$2,146
Methylprednisolone331$1,989
Celecoxib81$1,635
Tramadol Hcl119$709
Prednisone68$258
Cyclobenzaprine Hcl19$147
Diclofenac Sodium25$114
Meloxicam39$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bannockburn

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →